Health benefits and risks of reporting HIV-infected individuals by name

American Journal of Public Health

Volumn 88, Issue 6, 1998, Pages 876-879

  Colfax, Grant Nash ^a   Bindman, Andrew B ^b  

^a AIDS Office San Francisco   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HEALTH CARE POLICY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; MEDICAL DOCUMENTATION; MEDICAL RECORD; PRIVACY; RISK BENEFIT ANALYSIS;

EID: 0031778775     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.88.6.876     Document Type: Article

References (38)

1. Steinbrook R. Battling HIV on many fronts. N Engl J Med. 1997;37:779-781.
2. National HIV Surveillance: Addition to the National Public Health Surveillance System. Atlanta, Ga: Council of State and Territorial Epidemiologists; 1997. CSTE Position Statement ID-4.
3. Reporting of Acquired Immunodeficiency Syndrome and Infection with Human Immunodeficiency Virus. 8:57-2.2. Trenton, NJ: New Jersey Department of Public Health; 1992.
4. Fla Stat § 84.25.
5. Case definitions for infectious conditions under public health surveillance. MMWR CDC Surveill Summ. 1997;46(RR 10):2.
6. Recommended Nationally Reportable Diseases and Conditions by State. Atlanta, Ga: Council of State and Territorial Epidemiologists; 1996.
7. National electronic telecommunications system for surveillance - United States, 1990-1991. MMWR CDC Surveill Summ. 1991;40(29): 502-503.
8. Buehler JW, Berkelman RL, Stehr-Green JK. The completeness of AIDS surveillance. J Aquir Immune Defic Syndr. 1992;5:257-264.
9. Rosenbaum L, Buehler J, Morgan M, et al. The completeness of AIDS case reporting, 1988: a multisite collaborative surveillance project. Am J Public Health. 1992;82:1495-1499.
10. Howorth T, Hoffman R, Cohn D, Davidson A. Anonymous HIV testing, does it attract clients who would not seek confidential testing? AIDS Public Policy J. Winter 1994:182-189.
11. Hertz-Picciotto I, Lee LW, Hoyo C. HIV test-seeking before and after the restriction of anonymous testing in North Carolina. Am J Public Health. 1996;86:1446-1450.
12. Fehrs LJ, Fleming D, Foster LR, et al. Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet. 1988;2: 379-382.
13. Hirano D, Gellert GA, Fleming K, Boyd D, Englender SJ, Hawks H. Anonymous HIV testing: the impact of availability on demand in Arizona. Am J Public Health. 1994;84: 2008-2010.
14. Centers for Disease Control and Prevention. Evaluation of HIV case surveillance through the use of non-name unique identifiers: Maryland and Texas, 1994-1996. MMWR Morb Mortal Weekly Rep. 1998;46:1254-1257.
15. Smith E, Rix BA, Melbye M. Mandatory anonymous HIV surveillance in Denmark: the first results of a new system. Am J Public Health. 1994;84:1929-1932.
16. McDonald AM, Gertig DM, Crofts N, Kaldor JM. A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee. Am J Public Health. 1994;84:1923-1928 (see comments).
17. The Global Eradication of Smallpox. Geneva, Switzerland: World Health Organization; 1980.
18. Frieden TR, Fujiwara PI, Washko RM, Hamburg MAH. Tuberculosis in New York City -turning the tide. N Engl J Med. 1995; 333:229-233.
19. Centers for Disease Control and Prevention. Public health uses of HIV-infection reports -South Carolina, 1986-1991. MMWR Morb Mortal Wkly Rep. 1992;41:247-249.
20. Hirano D, England B, Hoff C, et al. Reporting HIV infections. J Acquir Immune Defic Syndr. 1994;7:417-418.
21. Landis SE, Schoenbach VJ, Weber DJ, et al. Results of a randomized trial of partner notification in cases of HIV infection in North Carolina. N Engl J Med. 1992;326:101-106.
22. Rahman M, Fuki T. Partner notification program and possibility of including it in the HIV prevention strategies in Japan. J Epidemiol. 1996;6:158-165.
23. Rutherford G, Woo J. Contact tracing and the control of human immunodeficiency virus infection. JAMA. 1988;259:3609-3610.
24. Bayer R, Fairchild CA. AIDS and the limits of control: public health orders, quarantine, and recalcitrant behavior. Am J Public Health. 1993;83:1471-1476.
25. Levine C, Stein GL. What's in a name? The policy implications of the CDC definition of AIDS. Law Med Health Care. 1991;19:278-290.
26. Shilts R. And the Band Played On. New York, NY: St. Martin's Press; 1987.
27. Florida investigates breach of confidentiality in HIV records. AIDS Policy Law. 1996;11 (18):1.
28. Wortely PM, Chu SY, Diaz T, et al. HIV testing patterns: where, why, and when were people with AIDS tested for HIV? AIDS. 1995;9:487-492.
29. Johnson W, Sy F, Jackson K. The impact of mandatory reporting of HIV seropositive persons in South Carolina. Presented at the IV International Conference on AIDS, Stockholm, 1988.
30. Meyer PA, Jones JL, Garrison CZ, Dowda H. Comparison of individuals receiving anonymous and confidential testing for HIV. South Med J. 1994;87:344-347.
31. Kegeles SM, Coates TJ, Lo B, Catania JA. Mandatory reporting of HIV testing would deter men from being tested. JAMA. 1989;261:1275-1276.
32. Fordyce EJ, Sambula S, Stoneburner R. Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being tested. JAMA. 1989;262:349.
33. Kegeles SM, Catania JA, Coates TJ, Pollack LM, Lo B. Many people who seek anonymous HIV-antibody testing would avoid it under other circumstances. J Acquir Immune Defic Syndr. 1990;4:585-586.
34. Bayer R. Private Acts, Social Consequences. New York, NY: Collier Macmillan; 1989.
35. Judson F, Vernon T. The impact of AIDS on state and local health departments: issues and a few answers. Am J Public Health. 1988; 78:387-393.
36. Hoffman R, Wolf F, Wood R, Raevsky C, Vernon T. Confidential versus anonymous human immunodeficiency virus antibody testing [letter]. West J Med. 1990;152:75.
37. Hecht FM, Colman S, Lehman, JS, et al. Named reporting of HIV: attitudes and knowledge of those at risk. J Gen Intern Med. 1997;12(suppl 1):108.
38. A Survey of Public Health Infectious Disease Surveillance in the United States. Atlanta, Ga: Council of State and Territorial Epidemiologists; 1992.